Myomo Inc (NYSEMKT:MYO)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research report issued on Monday.

Myomo (NYSEMKT:MYO) traded down 3.6793% during trading on Monday, reaching $5.5866. The company’s stock had a trading volume of 706 shares. The firm’s market cap is $34.01 million. The stock’s 50 day moving average is $6.50 and its 200-day moving average is $8.74. Myomo has a 52 week low of $5.12 and a 52 week high of $23.20.

ILLEGAL ACTIVITY WARNING: This news story was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/04/myomo-inc-myo-rating-reiterated-by-hc-wainwright.html.

Myomo Company Profile

Myomo, Inc is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke.

Receive News & Stock Ratings for Myomo Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo Inc and related stocks with our FREE daily email newsletter.